Salt Lake City, UT, United States of America

Susan L Neuhausen


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susan L Neuhausen: A Pioneer in Prostate Cancer Genetics

Introduction

Susan L Neuhausen is a notable inventor in the field of human genetics, particularly recognized for her contributions to understanding prostate cancer susceptibility. Based in Salt Lake City, Utah, she has made significant strides in identifying genetic factors that predispose individuals to prostate cancer. Her work has implications for diagnosis, prognosis, and therapy in cancer treatment.

Latest Patents

Susan L Neuhausen holds a patent for the invention titled "Chromosome 17P-linked prostate cancer susceptibility gene." This invention relates to methods and materials used to isolate and detect a human prostate cancer predisposing gene (HPC2). The patent details the identification of germline mutations in the HPC2 gene, which are crucial for diagnosing predisposition to prostate cancer. Furthermore, it discusses presymptomatic therapy for individuals carrying deleterious alleles of the HPC2 gene. The invention also addresses somatic mutations in the HPC2 gene and their relevance in diagnosing and prognosing human prostate cancer, as well as other cancers. Additionally, it explores therapeutic approaches for cancers with mutations in the HPC2 gene, including gene therapy and drug screening.

Career Highlights

Throughout her career, Susan has worked with prominent organizations such as Myriad Genetics, Inc. and the University of Utah Research Foundation. Her research has significantly advanced the understanding of genetic factors in cancer susceptibility, making her a key figure in the field.

Collaborations

Susan has collaborated with esteemed colleagues, including Sean V Tavtigian and David H-f Teng, contributing to the collective knowledge and research in cancer genetics.

Conclusion

Susan L Neuhausen's innovative work in identifying genetic markers for prostate cancer has paved the way for advancements in diagnosis and treatment. Her contributions continue to impact the field of human genetics and cancer research significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…